GGrantIndex
Sort

39,280 grants matching leukemia

Stem Cell Gene Therapy for AIDS

$332,425
R. Paul Johnson · Harvard Medical School · R01 · FY2006 · CA

Genomics of AML Relapse

$332,388
John F Dipersio · Washington University · P01 · FY2015 · CA

Neuroblastoma Tumor Suppressor Genes in Zebrafish

$332,386
A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2007 · CA

Genomic Profiling of Childhood de novo and Relapsed AML

$332,385
Stanford University · R01 · FY2005 · CA

GENE THERAPY BY PHENOTYPIC KNOCKOUT OF HIV CORECEPTORS

$332,376
Dana-Farber Cancer Institute · R01 · FY2002 · AI

NK Cells and Their Receptor in Leukemia Therapy

$332,372
Jeffrey S Miller · University Of Minnesota · P01 · FY2013 · CA

Cell and Tissue Imaging Shared Resources Core

$332,357
Camenzind G Robinson · St. Jude Children'S Research Hospital · P30 · FY2023 · CA

Cell and Tissue Imaging Shared Resources Core

$332,357
Camenzind G Robinson · St. Jude Children'S Research Hospital · P30 · FY2022 · CA

Cell and Tissue Imaging Shared Resources Core

$332,357
Victoria Centonze Frohlich · St. Jude Children'S Research Hospital · P30 · FY2020 · CA

Proximo-distal patterning in the Drosophila appendages

$332,355
Richard S Mann · Columbia University Health Sciences · R01 · FY2006 · GM

Survival Mechanisms in Leukemic NK Cells

$332,340
Thomas P Loughran · University Of Virginia · R01 · FY2016 · CA

Engineering of computational receptors and gene circuits for T-cell immunotherapy

$332,333
Yvonne Yu-Hsuan Chen · University Of California Los Angeles · DP5 · FY2013 · OD

Small molecules that maintain self-renewal of hESCs without growth factors

$332,325
Xiang-Lei Yang · Scripps Research Institute, The · R21 · FY2010 · HD

Genomic Prediction of Doxorubicin-Induced Cardiotoxicity

$332,271
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2022 · CA

FUNCTION AND BIOLOGY OF EUKARYOTIC DNA TOPOISOMERASES

$332,200
Vanderbilt University · R01 · FY2002 · GM

FUNCTION AND BIOLOGY OF EUKARYOTIC DNA TOPOISOMERASES

$332,200
Vanderbilt University · R01 · FY2003 · GM

Mechanism(s) of TAL-1/SCL-mediated Leukemogenesis

$332,186
Univ Of Massachusetts Med Sch Worcester · R01 · FY2005 · CA

Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II

$332,167
Vasily M Studitsky · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · GM

Pathways of Immune Evasion in Acute Myeloid Leukemia

$332,159
Evan Ferguson Lind · Oregon Health & Science University · R01 · FY2024 · CA

Core A - Clinical Database.

$332,134
Peter Westervelt · Washington University · P01 · FY2022 · CA

Targeting EGR1 signaling pathways in diffuse large B cell lymphoma

$332,133
Lixin Rui · University Of Wisconsin-Madison · R01 · FY2024 · CA

Regulators of Cancer-Specific DNA Hypermethylation.

$332,101
Jean-Pierre J Issa · Temple Univ Of The Commonwealth · R01 · FY2012 · CA

Role of epigenetic alterations in the bone marrow niche to aging-related hematopoietic clonality leading to IDH mutant MDS and AML

$332,100
Stavroula Kousteni · Columbia University Health Sciences · R56 · FY2021 · AG

Mechanism(s) of TAL-1/SCL-mediated Leukemogenesis

$332,100
Univ Of Massachusetts Med Sch Worcester · R01 · FY2004 · CA

Neuronal Development, Injury and Regeneration in Retina

$332,094
Peter F Hitchcock · University Of Michigan At Ann Arbor · R01 · FY2007 · EY